Molecular genetic framework underlying pulmonary arterial hypertension.

Area of Science:

• Cardiovascular Genetics
• Pulmonary Medicine
• Molecular Biology

Background:

• Pulmonary arterial hypertension (PAH) is a progressive vascular disease characterized by pulmonary arteriole occlusion, leading to right ventricular failure.
• Endothelial dysfunction and smooth muscle cell proliferation are key pathological features of PAH.
• Genetic factors play a significant role in PAH development and progression.

Purpose of the Study:

• To review recent advances in understanding the molecular genetics of pulmonary arterial hypertension (PAH).
• To highlight the identification of novel genetic variants and pathways implicated in PAH.
• To discuss the clinical implications of genetic findings for diagnosis and therapeutic interventions.

Main Methods:

• Review of high-throughput sequencing approaches for identifying genetic variants.
• Analysis of genetic data from familial and sporadic PAH cases.
• Integration of findings from genetic studies with known molecular pathways in PAH.

Main Results:

• Identification of BMPR2 as a key gene, alongside other genes like KCNK3, ABCC8, TBX4, and SOX17, involved in PAH.
• Elucidation of multiple genetic pathways contributing to PAH susceptibility and disease progression.
• Evidence supporting a complex Mendelian inheritance model for PAH with incomplete penetrance and genetic heterogeneity.

Conclusions:

• Genetic research has significantly advanced the understanding of PAH's molecular basis.
• Identifying genetic variants offers insights into disease mechanisms and potential therapeutic targets.
• Genetic findings have implications for clinical management, including risk assessment and personalized medicine approaches for PAH.